Table 3. Adverse events occurring at any grade in the study subjects (n = 50).
| All grades, no. (%) | Grade ≥ 3, no. (%) | |
|---|---|---|
| Hematologic | ||
| Leukopenia | 46 (92) | 23 (46) |
| Neutropenia | 39 (78) | 23 (46) |
| Anemia | 50 (100) | 3 (6) |
| Thrombocytopenia | 33 (66) | 2 (4) |
| Febrile neutropenia | 5 (10) | 5 (10) |
| Nonhematologic | ||
| Anorexia | 26 (52) | 2 (4) |
| Constipation | 33 (66) | 0 (0) |
| Mucosal inflammation | 21 (42) | 0 (0) |
| Esophagitis | 31 (62) | 0 (0) |
| Fatigue | 24 (48) | 2 (4) |
| Nausea | 27 (54) | 2 (4) |
| Vomiting | 9 (18) | 0 (0) |
| Diarrhea | 5 (10) | 0 (0) |
| Pyrexia | 14 (28) | 0 (0) |
| Elevated AST | 12 (24) | 0 (0) |
| Elevated ALT | 18 (36) | 0 (0) |
| Increased total bilirubin | 9 (18) | 0 (0) |
| Increased creatinine | 17 (34) | 2 (4) |
| Hyperkalemia | 29 (58) | 1 (2) |
| Hyponatremia | 31 (62) | 8 (16) |
| Pneumonitis | 8 (16) | 1 (2) |
| Esophageal perforation | 3 (6) | 3 (6) |
| Pericardial effusion | 6 (12) | 0 (0) |
Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase.